Recommendations of the Brazilian College of Radiology, the Brazilian Society of Mastology and the Brazilian Federation of Gynecology and Obstetrics Associations for breast cancer screening in Brazil

Objective: To present the updated recommendations of the Brazilian College of Radiology and Imaging Diagnosis, the Brazilian Society of Mastology and the Brazilian Federation of Gynecology and Obstetrics Associations for breast cancer screening in Brazil. Methods: Between January 2012 and July 2022, searches for scientific evidence published in MEDLINE, Embase, Cochrane Library, EBSCO, CINAHL and LILACS were carried out. The recommendations were based on this evidence, with the consensus of a committee of experts from the three institutions. Recommendations: The annual mammography screening is recommended for normal-risk patients aged between 40 and 74 years. For women aged more than 75 years, it is reserved for those whose life expectancy is longer than seven years. Women whose risk is higher than normal, such as those with dense breasts, personal history of atypical lobular hyperplasia, classic in situ lobular carcinoma, atypical ductal hyperplasia, women undergoing breast cancer treatment or thoracic irradiation before the age of 30, or those with genetic mutation or strong family history, benefit from complementary screening, being considered in an individual manner. Tomosynthesis is an evolution of mammography and should be considered in screening whenever accessible and available.

[1]  L. Moy,et al.  Women 75 Years Old or Older: To Screen or Not to Screen? , 2023, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  L. Moy,et al.  Breast Cancer Screening for Women at Higher-than-Average Risk: Updated Recommendations from the ACR. , 2023, Journal of the American College of Radiology : JACR.

[3]  E. Conant,et al.  Mammographic Screening in Routine Practice: Multisite Study of Digital Breast Tomosynthesis and Digital Mammography Screenings. , 2023, Radiology.

[4]  J. Damilakis,et al.  How to establish and use local diagnostic reference levels: an ESR EuroSafe Imaging expert statement , 2023, Insights into Imaging.

[5]  A. Valachis,et al.  Yield of Surveillance Imaging After Mastectomy With or Without Reconstruction for Patients With Prior Breast Cancer , 2022, JAMA network open.

[6]  H. Hense,et al.  Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial. , 2022, The Lancet. Oncology.

[7]  O. Olopade,et al.  Detection of germline variants in Brazilian breast cancer patients using multigene panel testing , 2022, Scientific Reports.

[8]  S. Duffy,et al.  A Randomized Trial Comparing Breast Cancer Incidence and Interval Cancers after Tomosynthesis Plus Mammography versus Mammography Alone. , 2022, Radiology.

[9]  J. Cairns,et al.  Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway , 2021, Quality of Life Research.

[10]  N. Ohuchi,et al.  Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography , 2021, JAMA network open.

[11]  Tong Wu,et al.  The Added Value of Supplemental Breast Ultrasound Screening for Women With Dense Breasts: A Single Center Canadian Experience , 2021, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[12]  M. McEntee,et al.  Diagnostic Performance of Adjunctive Imaging Modalities Compared to Mammography Alone in Women with Non-Dense and Dense Breasts: A Systematic Review and Meta-Analysis. , 2021, Clinical breast cancer.

[13]  S. Duffy,et al.  Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer , 2021, Journal of medical screening.

[14]  M. McInnes,et al.  Performance of Digital Breast Tomosynthesis, Synthetic Mammography and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis. , 2020, Journal of the National Cancer Institute.

[15]  Artur Iuri Alves de Sousa,et al.  Editorial , 2020, Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia.

[16]  Christoph I. Lee,et al.  Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density , 2020, JAMA network open.

[17]  E. Schröck,et al.  Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes , 2020, European Journal of Human Genetics.

[18]  Ronilda C. Lacson,et al.  Comparing Tumor Characteristics and Rates of Breast Cancers Detected by Screening Digital Breast Tomosynthesis and Full-Field Digital Mammography. , 2020, AJR. American journal of roentgenology.

[19]  B. Hankey,et al.  Surveillance, Epidemiology, and End Results Program , 2020, Definitions.

[20]  Janice S. Sung,et al.  Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer. , 2020, Journal of breast imaging.

[21]  P. Skaane,et al.  Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway. , 2019, Radiology.

[22]  C. Barrios,et al.  Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115) , 2019, Journal of global oncology.

[23]  N. Karssemeijer,et al.  MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. , 2019, The Lancet. Oncology.

[24]  Jack Cuzick,et al.  Risk Models for Breast Cancer and Their Validation , 2019, Statistical science : a review journal of the Institute of Mathematical Statistics.

[25]  L. Rabeneck,et al.  Performance measures of magnetic resonance imaging plus mammography in the High Risk Ontario Breast Screening Program. , 2019, Journal of the National Cancer Institute.

[26]  C. Lehman,et al.  Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. , 2019, Radiology.

[27]  Dorothy A. Sippo,et al.  Performance of Screening Breast MRI across Women with Different Elevated Breast Cancer Risk Indications. , 2019, Radiology.

[28]  L. Thuler,et al.  Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. , 2019, European journal of breast health.

[29]  C. Barrios,et al.  Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study. , 2019, Breast.

[30]  N. Karssemeijer,et al.  Abstract P6-13-01: MRI breast cancer screening compared to mammography in women with a familial risk: A multicenter randomized controlled trial , 2019, Poster Session Abstracts.

[31]  Stephen W Duffy,et al.  Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis , 2018, British Journal of Cancer.

[32]  M. Greuter,et al.  Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts – a systematic review and meta-analysis , 2018, BMC Cancer.

[33]  W. Moon,et al.  Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy , 2017, JAMA oncology.

[34]  Ellyete de Oliveira Canella,et al.  Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations , 2017, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.

[35]  E. Paci,et al.  Corrigendum to "Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy" [Eur J Cancer 75 (April 2017) 109-116]. , 2017, European journal of cancer.

[36]  Ellyete de Oliveira Canella,et al.  Breast cancer screening: updated recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations , 2017, Radiologia brasileira.

[37]  S. J. Rhee,et al.  Benefit of adding digital breast tomosynthesis to digital mammography for breast cancer screening focused on cancer characteristics: a meta-analysis , 2017, Breast Cancer Research and Treatment.

[38]  Wendy B DeMartini,et al.  Abstract P3-01-01: Comparative performance of surveillance mammography and breast MRI in women with a history of breast cancer , 2017 .

[39]  Wendy B DeMartini,et al.  Screening MRI in Women With a Personal History of Breast Cancer. , 2016, Journal of the National Cancer Institute.

[40]  Ellen Warner,et al.  Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis , 2016, British Journal of Cancer.

[41]  T. Endo,et al.  Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial , 2016, The Lancet.

[42]  Karla Kerlikowske,et al.  Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening , 2016, Annals of Internal Medicine.

[43]  D. Miglioretti,et al.  Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. , 2015, JAMA oncology.

[44]  Dorothy A. Sippo,et al.  Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate. , 2015, Academic radiology.

[45]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[46]  S. Feigenberg,et al.  Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors , 2015, SpringerPlus.

[47]  J. Weigert,et al.  The Connecticut Experiments Second Year: Ultrasound in the Screening of Women with Dense Breasts , 2015, The breast journal.

[48]  Ralph T. Wynn,et al.  Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study. , 2015, Radiology.

[49]  D. Noh,et al.  Breast MR imaging screening in women with a history of breast conservation therapy. , 2014, Radiology.

[50]  Emily F Conant,et al.  Breast cancer screening using tomosynthesis in combination with digital mammography. , 2014, JAMA.

[51]  L. Walter,et al.  Screening mammography in older women: a review. , 2014, JAMA.

[52]  Derek C. Radisky,et al.  Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study , 2014, Cancer Prevention Research.

[53]  C. Ronckers,et al.  Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. , 2013, The Lancet. Oncology.

[54]  D. Miglioretti,et al.  Risk Factors for Second Screen-Detected or Interval Breast Cancers in Women with a Personal History of Breast Cancer Participating in Mammography Screening , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[55]  C. Ferreira,et al.  Recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para rastreamento do câncer de mama por métodos de imagem , 2012 .

[56]  T. Lister,et al.  Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  Etta D Pisano,et al.  Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. , 2012, JAMA.

[58]  Mark A Helvie,et al.  United States Preventive Services Task Force screening mammography recommendations: science ignored. , 2011, AJR. American journal of roentgenology.

[59]  Harry J de Koning,et al.  BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  J. Reis-Filho,et al.  Breast cancer precursors revisited: molecular features and progression pathways , 2010, Histopathology.

[61]  Judith Abrams,et al.  Breast Cancer Incidence in a Cohort of Women with Benign Breast Disease from a Multiethnic, Primary Health Care Population , 2007, The breast journal.

[62]  G. Colditz,et al.  The influence of family history on breast cancer risk in women with biopsy‐confirmed benign breast disease , 2006, Cancer.

[63]  G. Colditz,et al.  A prospective study of benign breast disease and the risk of breast cancer , 1992, JAMA.

[64]  W. Dupont,et al.  Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. , 1991, Human pathology.

[65]  P. Levine,et al.  Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. , 1985, Journal of the National Cancer Institute.

[66]  Jane M Lange,et al.  Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy , 2017, JAMA oncology.

[67]  M. Riviere.  Essai Sur La Nature Des Vrilles En Particulier Et Sur La Disposition Des Organes Appendiculaires De La Vigne En Général , 1879 .